The immune response combines extraordinary specificity of recognition with extremely complex control mechanisms that govern its effector mechanisms. Childhood primary immunodeficiency disorders can be viewed as """"""""experiments of nature"""""""" in which a discrete genetic defect affects the expression and/or the structure and function of essential lymphocyte proteins and results in immune dysfunctions. A molecular or genetic definition of primary immunodeficiencies is essential for accurate diagnosis and therapy of the disorders and for better understanding of normal immune functions. In this program project we propose to study a limited set of immunologic diseases, namely childhood T cell immunodeficiency diseases and atopic dermatitis. We will use recently acquired knowledge of T cell receptor structure and T cell activation to define the immunologic defects in these diseases. In parallel we will attempt to mimic those diseases in animal models by using the powerful tools of modern genetic engineering and DNA transfer into mouse embryos. The definition of T cell immunodeficiencies and immunological skin disorders in mice will permit a better understanding of these diseases. Once the objectives have been reached, the future directions of the program lead undoubtedly toward gene therapy via bone marrow transplant. As such, the model systems described in this proposal may have a wider impact on other immunological diseases (e.g., autoimmune diseases). The prospect for generating mutations in preselected genes of the immune system not only will permit the derivation of precise animal models of human hereditary diseases but also will mark the beginning of a systematic genetic dissection of the developmental processes that play a role in the ontogeny of the immune system.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program Projects (P01)
Project #
7P01AI028046-03
Application #
3091988
Study Section
Allergy & Clinical Immunology-1 (AITC)
Project Start
1989-09-30
Project End
1994-07-31
Budget Start
1991-08-01
Budget End
1992-07-31
Support Year
3
Fiscal Year
1991
Total Cost
Indirect Cost
Name
Beth Israel Deaconess Medical Center
Department
Type
DUNS #
076593722
City
Boston
State
MA
Country
United States
Zip Code
02215
Tsytsykova, A V; Tsitsikov, E N; Geha, R S (1996) The CD40L promoter contains nuclear factor of activated T cells-binding motifs which require AP-1 binding for activation of transcription. J Biol Chem 271:3763-70
Ramesh, N; Fuleihan, R; Swinton, P et al. (1995) A point mutation in exon 2 of the CD40 ligand gene causes the simultaneous expression of two defective mRNA species in X-linked hyperimmunoglobulinemia M. Hum Mol Genet 4:759-61
Levelt, C N; Mombaerts, P; Wang, B et al. (1995) Regulation of thymocyte development through CD3: functional dissociation between p56lck and CD3 sigma in early thymic selection. Immunity 3:215-22
Simpson, S; Hollander, G; She, J et al. (1995) Selection of peripheral and intestinal T lymphocytes lacking CD3 zeta. Int Immunol 7:287-93
Castigli, E; Alt, F W; Davidson, L et al. (1994) CD40-deficient mice generated by recombination-activating gene-2-deficient blastocyst complementation. Proc Natl Acad Sci U S A 91:12135-9
Tsitsikov, E N; Ramesh, N; Geha, R S (1994) Structure of the murine CD40 ligand gene. Mol Immunol 31:895-900
Wang, B; Biron, C; She, J et al. (1994) A block in both early T lymphocyte and natural killer cell development in transgenic mice with high-copy numbers of the human CD3E gene. Proc Natl Acad Sci U S A 91:9402-6
Spertini, F; Wang, A V; Chatila, T et al. (1994) Engagement of the common leukocyte antigen CD45 induces homotypic adhesion of activated human T cells. J Immunol 153:1593-602
Su, H C; Orange, J S; Fast, L D et al. (1994) IL-2-dependent NK cell responses discovered in virus-infected beta 2-microglobulin-deficient mice. J Immunol 153:5674-81
Liu, C P; Ueda, R; She, J et al. (1993) Abnormal T cell development in CD3-zeta-/- mutant mice and identification of a novel T cell population in the intestine. EMBO J 12:4863-75

Showing the most recent 10 out of 19 publications